Enfusion, Inc. (“Enfusion”) (NYSE:ENFN), a leading provider of cloud-based investment management software and services, today announced that its Board of Directors (the “Board”) has appointed Oleg Movchan, currently a member of the Board, as Interim Chief Executive Officer, effective August 21, 2022. Mr. Movchan succeeds Thomas Kim, who has resigned as CEO and as a Director of the Company so that he can spend more time with his family.
Autoliv’s Cost Reduction Plan To Garner $25M In Savings In FY24 Amid Stronger Pricing, Analyst Says
Mizuho analyst Jason Getz reiterated a Buy rating on Autoliv, Inc. (NYSE: ALV),
